Imagen de Portada

A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Cesar Torres, Gregory Levin, Daniel Rubin, William Koh, Rebecca Chiu, Thomas Permutt
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Pharmaceutical Statistics
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Handling Missing Data in Participants with Baseline but No Post‐Baseline Data
por: Craig Mallinckrodt, et al.
Publicado: (2026)

A Federated Data Analysis Approach for the Evaluation of Surrogate Endpoints
por: Dries De Witte, et al.
Publicado: (2025)

Target Aggregate Data Adjustment Method for Transportability Analysis Utilizing Summary‐Level Data From the Target Population
por: Yichen Yan, et al.
Publicado: (2025)

Optimal Cut‐Point Selection Methods Under Binary Classification When Subclasses Are Involved
por: Jia Wang, et al.
Publicado: (2024)

Multiple Comparisons With Overdispersed Multinomial Data: Methods, Properties and Application
por: Sören Budig, et al.
Publicado: (2026)

Potential Bias Models With Bayesian Shrinkage Priors for Dynamic Borrowing of Multiple Historical Control Data
por: Tomohiro Ohigashi, et al.
Publicado: (2024)

Comparative Analyses of Bioequivalence Assessment Methods for In Vitro Permeation Test Data
por: Sami Leon, et al.
Publicado: (2024)

Real Effect or Bias? Good Practices for Evaluating the Robustness of Evidence From Comparative Observational Studies Through Quantitative Sensitivity Analysis for Unmeasured Confounding
por: Douglas Faries, et al.
Publicado: (2024)

Bayesian Hierarchical Models for Subgroup Analysis
por: Yun Wang, et al.
Publicado: (2024)

Using Propensity Score Weighting to Enhance the Operating Characteristics of Power Prior in Leveraging External Data to Augment a Traditional Clinical Study
por: Heng Li, et al.
Publicado: (2025)

Evaluating Safety Rules in Ongoing Dose‐Escalation Trials Using BOIN : A Comparative Analysis of Criteria and Their Impact on Dose‐Level Safety Assessments
por: Stefan Englert, et al.
Publicado: (2026)

Long‐Term Safety Evaluations in the Presence of Switching: Evaluation of Two Approaches
por: Sandra Schmeller, et al.
Publicado: (2025)

Bayesian Methods for Quality Tolerance Limit (QTL) Monitoring
por: J. C. Poythress, et al.
Publicado: (2024)

Designing and Evaluating Bayesian Advanced Adaptive Randomised Clinical Trials: A Practical Guide
por: Anders Granholm, et al.
Publicado: (2025)

Multiplicity Adjustment Methods for a Three‐Way Crossover Bioequivalence Study
por: David Hinds, et al.
Publicado: (2026)

Confidence Intervals for the Risk Difference Between Secondary and Primary Infection Based on the Method of Variance Estimates Recovery
por: Chao Chen, et al.
Publicado: (2024)

Leveraging Two‐Stage δ Global Sensibility Analysis Method to Inform Parameter Estimation in PBPK Models
por: Marina Cuquerella‐Gilabert, et al.
Publicado: (2026)

An Ensemble Classifier for Ordinal Outcomes in High‐Dimensional Genomics Data
por: Heranga K. Rathnasekara, et al.
Publicado: (2026)

Sample Size Estimation for Correlated Count Data With Changes in Dispersion
por: Jintong Hou, et al.
Publicado: (2025)

An Association Test for Ordinal Outcomes in Clustered Data With Informative Cluster Size
por: Hasika K. Wickrama Senevirathne, et al.
Publicado: (2026)

Correction to “Sample Size Estimation for Correlated Count Data With Changes in Dispersion”
Publicado: (2025)

Prediction Intervals for Overdispersed Binomial Endpoints and Their Application to Toxicological Historical Control Data
por: Max Menssen, et al.
Publicado: (2025)

Survival Analysis Without Sharing of Individual Patient Data by Using a Gaussian Copula
por: Federico Bonofiglio
Publicado: (2024)

Application of Causal Inference to Establish Assay Effect in the Absence of a Bridging Study: A Case Study of MenACWY ‐ CRM Conjugate Vaccine Data
por: Meike Adani, et al.
Publicado: (2026)

Getting (More Out of) Graphics—Practices and Principles of Data Visualisation. Data Science SeriesBy AntonyUnwin, Chapman & Hall/CRC, 2024. 446 pp. $ 74.99. ISBN: 978‐0‐36‐767399‐4
por: Wei Zhao
Publicado: (2025)

Penalized Variable Selection for Joint AFT Random‐Effect Model With Clustered Competing‐Risks Data
por: Lin Hao, et al.
Publicado: (2026)

Applying Bias Correction Methods to Build Hybrid Controls Using Real‐World Patients for a Phase IIb Randomized Controlled Trial of Baricitinib for Rheumatoid Arthritis
por: Heather J. Litman, et al.
Publicado: (2025)

A Statistical Concept for Conditional Marketing Authorisation Based on the Intermediate and Final Outcomes of a Single Confirmatory Randomised Clinical Trial
por: Xiaofei Liu, et al.
Publicado: (2026)

Applying the Principal Stratum Strategy in Equivalence Trials: A Case Study
por: Jerome Sepin, et al.
Publicado: (2025)

Generalizing Treatment Effect to a Target Population Without Individual Patient Data in a Real‐World Setting
por: Hui Quan, et al.
Publicado: (2024)

Do You Want to Stay Single? Considerations on Single‐Arm Trials in Drug Development and the Postregulatory Space
por: Yulia Dyachkova, et al.
Publicado: (2024)

Shrinkage priors for isotonic probability vectors and binary data modeling, with applications to dose–response modeling
por: Philip S. Boonstra, et al.
Publicado: (2024)

Using Off‐Treatment Sequential Multiple Imputation for Binary Outcomes to Address Intercurrent Events Handled by a Treatment Policy Strategy
por: Sunita Rehal, et al.
Publicado: (2026)

Simulation‐Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies
por: Chiara Micoli, et al.
Publicado: (2025)

Simulation‐based sample size calculations of marginal proportional means models for recurrent events with competing risks
por: Julie Funch Furberg, et al.
Publicado: (2024)

The Estimand Framework and Causal Inference: Complementary Not Competing Paradigms
por: Thomas Drury, et al.
Publicado: (2025)

Estimation of Treatment Policy Estimands for Continuous Outcomes Using Off‐Treatment Sequential Multiple Imputation
por: Thomas Drury, et al.
Publicado: (2024)

A practical guide to the appropriate analysis of eGFR data over time: A simulation study
por: Todd DeVries, et al.
Publicado: (2024)

Mixture Experimentation in Pharmaceutical Formulations: A Tutorial
por: Lynne B. Hare, et al.
Publicado: (2024)

Principles for Defining Estimands in Clinical Trials—A Proposal
por: Tobias Mütze, et al.
Publicado: (2024)